These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
64 related items for PubMed ID: 8074490
1. Prognostic value of increased lung tumor tissue cathepsin B. Ebert W, Knoch H, Werle B, Trefz G, Muley T, Spiess E. Anticancer Res; 1994; 14(3A):895-9. PubMed ID: 8074490 [Abstract] [Full Text] [Related]
2. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma. Werle B, Kraft C, Lah TT, Kos J, Schanzenbächer U, Kayser K, Ebert W, Spiess E. Cancer; 2000 Dec 01; 89(11):2282-91. PubMed ID: 11147599 [Abstract] [Full Text] [Related]
3. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer. Werle B, Kotzsch M, Lah TT, Kos J, Gabrijelcic-Geiger D, Spiess E, Schirren J, Ebert W, Fiehn W, Luther T, Magdolen V, Schmitt M, Harbeck N. Anticancer Res; 2004 Dec 01; 24(6):4147-61. PubMed ID: 15736466 [Abstract] [Full Text] [Related]
9. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent. Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G. Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326 [Abstract] [Full Text] [Related]
10. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer]. Padilla D, Cubo T, Molina JM, García M, De la Osa G, Palomino T, Pardo R, Martín J, Arévalo E, Hernández Calvo J. An Med Interna; 2003 Oct 15; 20(10):521-5. PubMed ID: 14585038 [Abstract] [Full Text] [Related]
14. Activity and tissue localization of cathepsin D in non small cell lung cancer. Chyczewski L, Płoński A, Chyczewska E, Furman M, Ostrowska H, Nikliński J, Kozłowski M. Rocz Akad Med Bialymst; 1997 Oct 15; 42 Suppl 1():217-29. PubMed ID: 9337539 [Abstract] [Full Text] [Related]
16. Cathepsin B expression and its correlation with tumor-associated laminin and tumor progression in gastric cancer. Khan A, Krishna M, Baker SP, Malhothra R, Banner BF. Arch Pathol Lab Med; 1998 Feb 15; 122(2):172-7. PubMed ID: 9499362 [Abstract] [Full Text] [Related]
17. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking. Schweiger A, Staib A, Werle B, Krasovec M, Lah TT, Ebert W, Turk V, Kos J. Br J Cancer; 2000 Feb 15; 82(4):782-8. PubMed ID: 10732746 [Abstract] [Full Text] [Related]
18. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC. Muley T, Dienemann H, Ebert W. Anticancer Res; 2003 Feb 15; 23(5b):4085-93. PubMed ID: 14666606 [Abstract] [Full Text] [Related]
19. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma. Russo A, Bazan V, Migliavacca M, Zanna I, Tubiolo C, Tumminello FM, Dardanoni G, Cajozzo M, Bazan P, Modica G, Latteri M, Tomasino RM, Colucci G, Gebbia N, Leto G. Clin Cancer Res; 2000 Jan 15; 6(1):178-84. PubMed ID: 10656448 [Abstract] [Full Text] [Related]
20. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score. Sinha AA, Quast BJ, Korkowski JC, Wilson MJ, Reddy PK, Ewing SL, Sloane BF, Gleason DF. Anticancer Res; 1999 Jan 15; 19(4B):2821-9. PubMed ID: 10652560 [Abstract] [Full Text] [Related] Page: [Next] [New Search]